Sunshine Biopharma Inc. short interest in 2026
In 2026, Sunshine Biopharma Inc.'s disclosed short interest ran from 6.26% of shares outstanding on 15 Jan 2026 to 2.24% on 31 Aug 2026, a change of -4.02 percentage points. The year's high was 6.26% on 15 Jan 2026 and its low 1.27% on 15 Jul 2026, averaging 3.37% across 12 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.13 days on 30 Jan 2026. Full history: Sunshine Biopharma Inc..
Cite this page
By year: 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 6.26% (15 Jan 2026)
- End of year
- 2.24% (31 Aug 2026)
- Change
- -4.02 pp
- High
- 6.26% (15 Jan 2026)
- Low
- 1.27% (15 Jul 2026)
- Average
- 3.37%
- Highest days to cover
- 8.13 (30 Jan 2026)
- SEC filings marked
- 4
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 6.26% | 7.34 | |
| 30 Jan 2026 | 5.73% | 8.13 | |
| 13 Feb 2026 | 4.79% | 6.15 | |
| 27 Feb 2026 | 4.60% | 6.77 | |
| 13 Mar 2026 | 3.39% | 3.68 | |
| 31 Mar 2026 | 2.85% | 4.99 | |
| 15 Apr 2026 | 2.74% | 3.35 | 10-K filed, results (8-K) |
| 30 Apr 2026 | 2.12% | 3.72 | |
| 15 Jul 2026 | 1.27% | 1.30 | 10-Q filed |
| 31 Jul 2026 | 2.58% | 1.00 | |
| 14 Aug 2026 | 1.91% | 1.00 | 10-Q filed |
| 31 Aug 2026 | 2.24% | 1.00 |
See also: Sunshine Biopharma Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.